This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (285)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Statistics and Research Methods  • Conflict of Interest  • Review  • Alert me on articles by topic

A Systematic Review

Justin E. Bekelman, AB; Yan Li, MPhil; Cary P. Gross, MD

JAMA. 2003;289:454-465.

Context  Despite increasing awareness about the potential impact of financial conflicts of interest on biomedical research, no comprehensive synthesis of the body of evidence relating to financial conflicts of interest has been performed.

Objective  To review original, quantitative studies on the extent, impact, and management of financial conflicts of interest in biomedical research.

Data Sources  Studies were identified by searching MEDLINE (January 1980-October 2002), the Web of Science citation database, references of articles, letters, commentaries, editorials, and books and by contacting experts.

Study Selection  All English-language studies containing original, quantitative data on financial relationships among industry, scientific investigators, and academic institutions were included. A total of 1664 citations were screened, 144 potentially eligible full articles were retrieved, and 37 studies met our inclusion criteria.

Data Extraction  One investigator (J.E.B.) extracted data from each of the 37 studies. The main outcomes were the prevalence of specific types of industry relationships, the relation between industry sponsorship and study outcome or investigator behavior, and the process for disclosure, review, and management of financial conflicts of interest.

Data Synthesis  Approximately one fourth of investigators have industry affiliations, and roughly two thirds of academic institutions hold equity in start-ups that sponsor research performed at the same institutions. Eight articles, which together evaluated 1140 original studies, assessed the relation between industry sponsorship and outcome in original research. Aggregating the results of these articles showed a statistically significant association between industry sponsorship and pro-industry conclusions (pooled Mantel-Haenszel odds ratio, 3.60; 95% confidence interval, 2.63-4.91). Industry sponsorship was also associated with restrictions on publication and data sharing. The approach to managing financial conflicts varied substantially across academic institutions and peer-reviewed journals.

Conclusions  Financial relationships among industry, scientific investigators, and academic institutions are widespread. Conflicts of interest arising from these ties can influence biomedical research in important ways.

Author Affiliations: Department of Medicine (Mr Bekelman and Dr Gross) and Department of Biostatistics (Ms Li), Yale University School of Medicine, New Haven, Conn.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Second-Generation Antipsychotics: Cost-Effectiveness, Policy Options, and Political Decision Making
Rosenheck et al.
Psychiatr. Serv. 2008;59:515-520.
ABSTRACT | FULL TEXT  

Disclosure of conflicts of interest in biomedical publications/La declaration de conflits d'interet dans les publications biomedicales
Miller
Canadian J. Anesthesia 2008;55:265-269.
FULL TEXT  

Has the hunt for conflicts of interest gone too far? No
Lee
BMJ 2008;336:477-477.
FULL TEXT  

Rethinking Antipsychotic Formulary Policy
Rosenheck et al.
Schizophr Bull 2008;34:375-380.
ABSTRACT | FULL TEXT  

Responses of Medical Schools to Institutional Conflicts of Interest
Ehringhaus et al.
JAMA 2008;299:665-671.
ABSTRACT | FULL TEXT  

Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study
Yank et al.
BMJ 2007;335:1202-1205.
ABSTRACT | FULL TEXT  

REPLY
Karkouti
Canadian J. Anesthesia 2007;54:1027-1028.
FULL TEXT  

Passing the Headline Test
Reider
Am J Sports Med 2007;35:1807-1808.
FULL TEXT  

The Relationship Between the Outcome of Studies of Autologous Chondrocyte Implantation and the Presence of Commercial Funding
Lubowitz et al.
Am J Sports Med 2007;35:1809-1816.
ABSTRACT | FULL TEXT  

Institutional Academic Industry Relationships
Campbell et al.
JAMA 2007;298:1779-1786.
ABSTRACT | FULL TEXT  

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
Vandenbroucke et al.
ANN INTERN MED 2007;147:W-163-W-194.
ABSTRACT | FULL TEXT  

Disclosure of Conflicts of Interest by Authors of Clinical Trials and Editorials in Oncology
Riechelmann et al.
JCO 2007;25:4642-4647.
ABSTRACT | FULL TEXT  

Financial Conflicts of Interest Among ASCO Annual Meeting Abstract Authors, Speakers, and Planners
Johnston and Go
JNCI J Natl Cancer Inst 2007;99:1415-1416.
FULL TEXT  

Evaluating the cost-effectiveness of reduced tardive dyskinesia with second-generation antipsychotics
Rosenheck
Br. J. Psychiatry 2007;191:238-245.
ABSTRACT | FULL TEXT  

The Sound and the Fury: Financial Conflicts of Interest in Oncology
Djulbegovic et al.
JCO 2007;25:3567-3569.
FULL TEXT  

Frequency, Type, and Monetary Value of Financial Conflicts of Interest in Cancer Clinical Research
Hampson et al.
JCO 2007;25:3609-3614.
ABSTRACT | FULL TEXT  

Attitudes Toward Research Participation and Investigator Conflicts of Interest Among Advanced Cancer Patients Participating in Early Phase Clinical Trials
Gray et al.
JCO 2007;25:3488-3494.
ABSTRACT | FULL TEXT  

Influence of drug company authorship and sponsorship on drug trial outcomes
Tungaraza and Poole
Br. J. Psychiatry 2007;191:82-83.
ABSTRACT | FULL TEXT  

Commercially Funded and United States-Based Research Is More Likely to Be Published; Good-Quality Studies with Negative Outcomes Are Not
Lynch et al.
JBJS 2007;89:1010-1018.
ABSTRACT | FULL TEXT  

Dr. Rosenheck and Colleagues Reply
ROSENHECK et al.
Am. J. Psychiatry 2007;164:678-680.
FULL TEXT  

The Legal and Ethical Issues Surrounding Financial Conflict of Interest in Orthopaedic Research
Okike and Kocher
JBJS 2007;89:910-913.
FULL TEXT  

Effects of Soft Drink Consumption on Nutrition and Health: A Systematic Review and Meta-Analysis
Vartanian et al.
Am. J. Public Health 2007;97:667-675.
ABSTRACT | FULL TEXT  

Conflict of Interest in Orthopaedic Research. An Association Between Findings and Funding in Scientific Presentations
Okike et al.
JBJS 2007;89:608-613.
ABSTRACT | FULL TEXT  

Influence of Industry on Renal Guideline Development Commentary: Keeping Our Eye on the Ball and Improving Chronic Kidney Disease Patient Outcomes
Nissenson
CJASN 2007;2:205-206.
FULL TEXT  

Evidence-based medicines for children: important implications for new therapies at all ages
Bush
Eur Respir J 2006;28:1069-1072.
FULL TEXT  

Conflicts of interest in biomedical research-- the FASEB guidelines
Brockway and Furcht
FASEB J. 2006;20:2435-2438.
ABSTRACT | FULL TEXT  

Financial Relationships between Institutional Review Board Members and Industry
Campbell et al.
NEJM 2006;355:2321-2329.
ABSTRACT | FULL TEXT  

Declaration of patent applications as financial interests: a survey of practice among authors of papers on molecular biology in Nature.
Mayer
J. Med. Ethics 2006;32:658-661.
ABSTRACT | FULL TEXT  

Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review
Jorgensen et al.
BMJ 2006;333:782.
ABSTRACT | FULL TEXT  

Processes of Inclusion, Cultures of Calculation, Structures of Power: Scientific Citizenship and the Royal Commission on Genetic Modification
Goven
Science Technology Human Values 2006;31:565-598.
ABSTRACT  

Manufactured uncertainty: protecting public health in the age of contested science and product defense.
MICHAELS
Ann. N. Y. Acad. Sci. 2006;1076:149-162.
ABSTRACT | FULL TEXT  

Translating Epoetin Research Into Practice: The Role Of Government And The Use Of Scientific Evidence
Cotter et al.
Health Aff (Millwood) 2006;25:1249-1259.
ABSTRACT | FULL TEXT  

How evidence-based are advertisements in journals regarding the subspecialty of rheumatology?
van Winkelen et al.
Rheumatology (Oxford) 2006;45:1154-1157.
ABSTRACT | FULL TEXT  

Symposium. Relationships with Industry: Critical for New Technology or an Unnecessary Evil?
Jacobs et al.
JBJS 2006;88:1650-1663.
FULL TEXT  

Conflicts of interest: how money clouds objectivity.
Smith
JRSM 2006;99:292-297.
FULL TEXT  

Financial Disclosures of Scientific Papers Presented at the 2003 RSNA Annual Meeting: Association with Reporting of Non-Food and Drug Administration-approved Uses of Industry Products
Brown et al.
Radiology 2006;239:849-855.
ABSTRACT | FULL TEXT  

Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.
Ridker and Torres
JAMA 2006;295:2270-2274.
ABSTRACT | FULL TEXT  

Origin and funding of the most frequently cited papers in medicine: database analysis
Patsopoulos et al.
BMJ 2006;332:1061-1064.
ABSTRACT | FULL TEXT  

Psychosocial Acute Treatment in Early-Episode Schizophrenia Disorders
Bola
Research on Social Work Practice 2006;16:263-275.
ABSTRACT  

Bias in Clinical Intervention Research
Gluud
Am J Epidemiol 2006;163:493-501.
ABSTRACT | FULL TEXT  

Systematic reviews of meta-analyses: applications and limitations
Delgado-Rodriguez
J. Epidemiol. Community Health 2006;60:90-92.
FULL TEXT  

Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
Heres et al.
Am. J. Psychiatry 2006;163:185-194.
ABSTRACT | FULL TEXT  

Health Industry Practices That Create Conflicts of Interest: A Policy Proposal for Academic Medical Centers
Brennan et al.
JAMA 2006;295:429-433.
ABSTRACT | FULL TEXT  

Industry Sponsorship and Financial Conflict of Interest in the Reporting of Clinical Trials in Psychiatry
Perlis et al.
Am. J. Psychiatry 2005;162:1957-1960.
ABSTRACT | FULL TEXT  

Regulating Academic-Industrial Research Relationships -- Solving Problems or Stifling Progress?
Stossel
NEJM 2005;353:1060-1065.
FULL TEXT  

Medical Students' Exposure to and Attitudes About Drug Company Interactions: A National Survey
Sierles et al.
JAMA 2005;294:1034-1042.
ABSTRACT | FULL TEXT  

Adding Value to Evidence-Based Clinical Guidelines
O'Connor
JAMA 2005;294:741-743.
FULL TEXT  

Reporting Conflicts of Interest, Financial Aspects of Research, and Role of Sponsors in Funded Studies
Fontanarosa et al.
JAMA 2005;294:110-111.
FULL TEXT  

The Perils of Relying on Interested Parties to Evaluate Scientific Quality
Wagner
Am. J. Public Health 2005;95:S99-S106.
ABSTRACT | FULL TEXT  

Challenges in Systematic Reviews of Therapeutic Devices and Procedures
Hartling et al.
ANN INTERN MED 2005;142:1100-1111.
ABSTRACT | FULL TEXT  

The Role of the Pharmaceutical Industry in Teaching Psychopharmacology: A Growing Problem
Brodkey
Acad. Psychiatry 2005;29:222-229.
ABSTRACT | FULL TEXT  

Ethics and scientific publication
Benos et al.
Adv. Physiol. Educ. 2005;29:59-74.
ABSTRACT | FULL TEXT  

Standards of Proof, Standards of Practice, and Proof of Standards: A Tale of Two Trials
Browman
JCO 2005;23:2583-2585.
FULL TEXT  

The availability of references and the sponsorship of original research cited in pharmaceutical advertisements
Cooper and Schriger
CMAJ 2005;172:487-491.
ABSTRACT | FULL TEXT  

Effect of Bisphosphonates on Periprosthetic Bone Mineral Density After Total Joint Arthroplasty. A Meta-Analysis
Bhandari et al.
JBJS 2005;87:293-301.
ABSTRACT | FULL TEXT  

Serving researchers, the impact factor and other conflicts of interest.
Sterk and Rabe
Eur Respir J 2005;25:3-5.
FULL TEXT  

Implications of Pharmaceutical Industry Funding on Clinical Research
Lexchin
The Annals of Pharmacotherapy 2005;39:194-197.
ABSTRACT | FULL TEXT  

A time of accelerated change in academic cardiovascular medicine: Implications for academic divisions of cardiology and their training programs
Califf et al.
J Am Coll Cardiol 2004;44:1957-1965.
ABSTRACT | FULL TEXT  

Users' guide to detecting misleading claims in clinical research reports
Montori et al.
BMJ 2004;329:1093-1096.
FULL TEXT  

Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry -- Self-Regulation in the Shadow of Federal Prosecution
Studdert et al.
NEJM 2004;351:1891-1900.
FULL TEXT  

Physician remuneration in industry-sponsored clinical trials: the case for standardized clinical trial budgets
Ferris and Naylor
CMAJ 2004;171:883-886.
FULL TEXT  

Travelling but never arriving: reflections of a retiring editor
Smith
BMJ 2004;329:242-244.
FULL TEXT  

Barriers to Clinical Trial Enrollment: Are State Mandates the Solution?
Hillner
JNCI J Natl Cancer Inst 2004;96:1048-1049.
FULL TEXT  

Cancer Trial Enrollment After State-Mandated Reimbursement
Gross et al.
JNCI J Natl Cancer Inst 2004;96:1063-1069.
ABSTRACT | FULL TEXT  

Meta-Analysis: Respiratory Tolerance to Regular {beta}2-Agonist Use in Patients with Asthma
Salpeter et al.
ANN INTERN MED 2004;140:802-813.
ABSTRACT | FULL TEXT  

From the Editors
Rabe and Sterk
Eur Respir J 2004;23:791-791.
FULL TEXT  

Industry Sponsorship and Authorship of Clinical Trials Over 20 Years
Buchkowsky and Jewesson
The Annals of Pharmacotherapy 2004;38:579-585.
ABSTRACT | FULL TEXT  

Does the type of competing interest statement affect readers' perceptions of the credibility of research? Randomised trial
Schroter et al.
BMJ 2004;328:742-743.
FULL TEXT  

Therapeutic Effects of Hyaluronic Acid on Osteoarthritis of the Knee. A Meta-Analysis of Randomized Controlled Trials
Wang et al.
JBJS 2004;86:538-545.
ABSTRACT | FULL TEXT  

Implementation Of Financial Disclosure Policies To Manage Conflicts Of Interest
Boyd et al.
Health Aff (Millwood) 2004;23:206-214.
ABSTRACT | FULL TEXT  

Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials
Bhandari et al.
CMAJ 2004;170:477-480.
ABSTRACT | FULL TEXT  

Facing the evidence: antidepressant treatment in children and adolescents
Garland
CMAJ 2004;170:489-491.
FULL TEXT  

How to spot bias and other potential problems in randomised controlled trials
Lewis and Warlow
J. Neurol. Neurosurg. Psychiatry 2004;75:181-187.
FULL TEXT  

Conflict of Interest in Orthopaedic Research
Zuckerman et al.
JBJS 2004;86:423-428.
ABSTRACT | FULL TEXT  

Biomedical conflicts of interest: a defence of the sequestration thesis--learning from the cases of Nancy Olivieri and David Healy
Schafer
J. Med. Ethics 2004;30:8-24.
ABSTRACT | FULL TEXT  

The Number, Quality, and Coverage of Randomized Controlled Trials in Nephrology
Strippoli et al.
J. Am. Soc. Nephrol. 2004;15:411-419.
ABSTRACT | FULL TEXT  

Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study
Jorgensen and Gotzsche
BMJ 2004;328:148.
ABSTRACT | FULL TEXT  

Efficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive Disorder
Price
JAMA 2004;291:40-41.
FULL TEXT  

Academic-Industrial Relationships in the Life Sciences
Blumenthal
NEJM 2003;349:2452-2459.
FULL TEXT  

Integrity and bias in academic psychiatry
Bola
Br. J. Psychiatry 2003;183:464-464.
FULL TEXT  

Eyes Wide Open
Chen
Sci Aging Knowl Environ 2003;2003:nf19-nf19.
ABSTRACT | FULL TEXT  

Cochrane at crossroads over drug company sponsorship
Moynihan
BMJ 2003;327:924-926.
FULL TEXT  

Association of Funding and Conclusions in Randomized Drug Trials: A Reflection of Treatment Effect or Adverse Events?
Als-Nielsen et al.
JAMA 2003;290:921-928.
ABSTRACT | FULL TEXT  

Handbook of Clinical Health Psychology, vol. 1: Medical Disorders and Behavioral Applications
OPTON
Am. J. Psychiatry 2003;160:1535-1537.
FULL TEXT  

Registering Clinical Trials
Dickersin and Rennie
JAMA 2003;290:516-523.
ABSTRACT | FULL TEXT  

Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin et al.
BMJ 2003;326:1167-1170.
ABSTRACT | FULL TEXT  

Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement
Moynihan
BMJ 2003;326:1189-1192.
FULL TEXT  

Effect of Industry Sponsorship on the Results of Biomedical Research
Sawka and Thabane
JAMA 2003;289:2502-2503.
FULL TEXT  

Getting it right: industry sponsorship and medical research
Baird
CMAJ 2003;168:1267-1269.
FULL TEXT  

The "Price" of Information
Heinig
J Hum Lact 2003;19:133-135.
 

Conflicts of Interest and AJRCCM: Restating Policy and a New Form to Upload
Tobin
Am. J. Respir. Crit. Care Med. 2003;167:1161-1164.
FULL TEXT  

The power of clinical trials and guidelines,and the challenge of conflicts of interest
Bruce Fye
J Am Coll Cardiol 2003;41:1237-1242.
FULL TEXT  

Central Challenges Facing the National Clinical Research Enterprise
Sung et al.
JAMA 2003;289:1278-1287.
ABSTRACT | FULL TEXT  

Industry is deeply involved in funding US research
Hopkins Tanne
BMJ 2003;326:179-179.
FULL TEXT